Cargando…
Melatonin in Alzheimer’s Disease
Alzheimer’s disease (AD), an age-related neurodegenerative disorder with progressive cognition deficit, is characterized by extracellular senile plaques (SP) of aggregated β-amyloid (Aβ) and intracellular neurofibrillary tangles, mainly containing the hyperphosphorylated microtubule-associated prote...
Autores principales: | Lin, Li, Huang, Qiong-Xia, Yang, Shu-Sheng, Chu, Jiang, Wang, Jian-Zhi, Tian, Qing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Molecular Diversity Preservation International (MDPI)
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3742260/ https://www.ncbi.nlm.nih.gov/pubmed/23857055 http://dx.doi.org/10.3390/ijms140714575 |
Ejemplares similares
-
Melatonin Therapy in Patients with Alzheimer’s Disease
por: Cardinali, Daniel P., et al.
Publicado: (2014) -
Regulation of Melatonin and Neurotransmission in Alzheimer’s Disease
por: Roy, Jaydeep, et al.
Publicado: (2021) -
Melatonin in Alzheimer's disease and other neurodegenerative disorders
por: Srinivasan, V, et al.
Publicado: (2006) -
The role of melatonin in the treatment of type 2 diabetes mellitus and Alzheimer's disease
por: Shen, Shengnan, et al.
Publicado: (2022) -
Melatonin levels in the Alzheimer’s disease continuum: a systematic review
por: Nous, Amber, et al.
Publicado: (2021)